For the Chronic Pain, these are very, very trying times. The pressure on opioid prescribing combined with the lack of any public policy progress in developing a chronic pain policy have created a malaise that is palpable. One very intelligent and somewhat iconoclastic chronic pain advocate is retired pharmacist Steve Ariens. He […]
Disability News Service, Resources, Diversity, Americans with Disabilities Act; Local and National.
Disability News Service, Resources, Diversity, Americans with Disabilities Act; Local and National.
Showing posts with label Pain. Show all posts
Showing posts with label Pain. Show all posts
Monday, October 30, 2017
Thursday, October 26, 2017
Americans Support for Legalizing Marijuana - All Time High in 2017
Americans continue to warm to legalizing marijuana, with 64% now saying its use should be made legal. This is the highest level of public support Gallup (News) has found for the proposal in nearly a half-century of measurement.
article by by Justin McCarthy for Gallup News | Oct 25, 2017
The latest figure, based on an Oct. 5-11 Gallup poll, follows shifts in the U.S. legal landscape regarding marijuana since Gallup's 2016 measure. While still illegal at the federal level, the issue was featured on a number of state ballot initiatives in 2016, and with eight states and the District of Columbia having fully legalized marijuana, more than one in five Americans live in a state where they can legally enjoy use of the drug.
Gallup first asked national adults about their views on the topic in 1969, when 12% supported legalization. Support had more than doubled by the end of the next decade but changed little throughout the 1980s and 1990s. By 2001, however, about a third of Americans favored legalizing marijuana, and support has steadily increased since. A majority of Americans have consistently supported legalizing marijuana since 2013.
The trajectory of Americans' views on marijuana is similar to that of their views on same-sex marriage over the past couple of decades. On both issues, about a quarter supported legalization in the late 1990s, and today 64% favor each. Over the past several years, Gallup has found that Americans have become more liberal on a variety of social issues.
Majority of Republicans Now Support Legalizing Marijuana
Democrats and independents have historically been much more likely than Republicans to say marijuana should be legalized. In 2009, Democrats were the first partisan group to see majority support for legalization, followed by independents in 2010.
This year for the first time, a majority of Republicans express support for legalizing marijuana; the current 51% is up nine percentage points from last year.
Bottom Line
As efforts to legalize marijuana at the state level continue to yield successes, public opinion, too, has shifted toward greater support. The Department of Justice under the current Republican administration has been perceived as hostile to state-level legalization. But Attorney General Jeff Sessions could find himself out of step with his own party if the current trends continue. Rank-and-file Republicans' views on the issue have evolved just as Democrats' and independents' have, though Republicans remain least likely to support legalizing pot.
SURVEY METHODS
Results for this Gallup poll are based on telephone interviews conducted Oct. 5-11, 2017, with a random sample of 1,028 adults, aged 18 and older, living in all 50 U.S. states and the District of Columbia. For results based on the total sample of national adults, the margin of sampling error is ±4 percentage points at the 95% confidence level. All reported margins of sampling error include computed design effects for weighting.
Each sample of national adults includes a minimum quota of 70% cellphone respondents and 30% landline respondents, with additional minimum quotas by time zone within region. Landline and cellular telephone numbers are selected using random-digit-dial methods.
View survey methodology, complete question responses and trends.
Learn more about how the Gallup Poll Social Series works.
http://news.gallup.com/poll/221018/record-high-support-legalizing-marijuana.aspx?g_source=Politics&g_medium=newsfeed&g_campaign=tiles
The latest figure, based on an Oct. 5-11 Gallup poll, follows shifts in the U.S. legal landscape regarding marijuana since Gallup's 2016 measure. While still illegal at the federal level, the issue was featured on a number of state ballot initiatives in 2016, and with eight states and the District of Columbia having fully legalized marijuana, more than one in five Americans live in a state where they can legally enjoy use of the drug.
Gallup first asked national adults about their views on the topic in 1969, when 12% supported legalization. Support had more than doubled by the end of the next decade but changed little throughout the 1980s and 1990s. By 2001, however, about a third of Americans favored legalizing marijuana, and support has steadily increased since. A majority of Americans have consistently supported legalizing marijuana since 2013.
The trajectory of Americans' views on marijuana is similar to that of their views on same-sex marriage over the past couple of decades. On both issues, about a quarter supported legalization in the late 1990s, and today 64% favor each. Over the past several years, Gallup has found that Americans have become more liberal on a variety of social issues.
Majority of Republicans Now Support Legalizing Marijuana
Democrats and independents have historically been much more likely than Republicans to say marijuana should be legalized. In 2009, Democrats were the first partisan group to see majority support for legalization, followed by independents in 2010.
This year for the first time, a majority of Republicans express support for legalizing marijuana; the current 51% is up nine percentage points from last year.
Bottom Line
As efforts to legalize marijuana at the state level continue to yield successes, public opinion, too, has shifted toward greater support. The Department of Justice under the current Republican administration has been perceived as hostile to state-level legalization. But Attorney General Jeff Sessions could find himself out of step with his own party if the current trends continue. Rank-and-file Republicans' views on the issue have evolved just as Democrats' and independents' have, though Republicans remain least likely to support legalizing pot.
SURVEY METHODS
Results for this Gallup poll are based on telephone interviews conducted Oct. 5-11, 2017, with a random sample of 1,028 adults, aged 18 and older, living in all 50 U.S. states and the District of Columbia. For results based on the total sample of national adults, the margin of sampling error is ±4 percentage points at the 95% confidence level. All reported margins of sampling error include computed design effects for weighting.
Each sample of national adults includes a minimum quota of 70% cellphone respondents and 30% landline respondents, with additional minimum quotas by time zone within region. Landline and cellular telephone numbers are selected using random-digit-dial methods.
View survey methodology, complete question responses and trends.
Learn more about how the Gallup Poll Social Series works.
http://news.gallup.com/poll/221018/record-high-support-legalizing-marijuana.aspx?g_source=Politics&g_medium=newsfeed&g_campaign=tiles
Monday, October 9, 2017
Plaintiffs Seek To Consolidate Lawsuits Against Prescription Opioid Drugmakers
Plaintiffs suing drug makers and distributors in dozens of cases tied to the opioid crisis are seeking to have the lawsuits consolidated and overseen by one federal judge in Ohio.
(AP) Oct. 7, 2017 - Plaintiffs suing drugmakers and distributors in dozens of cases tied to the opioid crisis are seeking to have the lawsuits consolidated and overseen by one federal judge in Ohio.
The Columbus Dispatch reports that plaintiffs want to consolidate 66 lawsuits from Alabama, Illinois, Kentucky, Ohio and West Virginia under a program known as "multidistrict litigation," or MDL. The plaintiffs are asking that the cases be heard by Chief U.S. District Judge Edmund Sargus Jr. in Columbus.
The idea is to have cases involving similar questions of fact and law consolidated, with the outcomes of test cases helping inform whether remaining plaintiffs proceed to trial, settle or withdraw their claims. Resolving the cases could take years.
A panel of judges will consider the MDL request Nov. 30.
Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed
The Columbus Dispatch reports that plaintiffs want to consolidate 66 lawsuits from Alabama, Illinois, Kentucky, Ohio and West Virginia under a program known as "multidistrict litigation," or MDL. The plaintiffs are asking that the cases be heard by Chief U.S. District Judge Edmund Sargus Jr. in Columbus.
The idea is to have cases involving similar questions of fact and law consolidated, with the outcomes of test cases helping inform whether remaining plaintiffs proceed to trial, settle or withdraw their claims. Resolving the cases could take years.
A panel of judges will consider the MDL request Nov. 30.
Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed
Thursday, October 5, 2017
U.S. Pain Foundation Statement On The CVS Pharmacy New Opium Policy
The U.S. Pain Foundation, a patient advocacy group has released the below statement on CVS Pharmacy limiting pain medications prescribed by medical professionals. As a person with long term medical conditions that require such medications, CVS and it's holding will no longer receive any of my business for the foreseeable future. - Jim W.
# # #
# # #
U.S. Pain Foundation
Oct. 2, 2017 - Many in the chronic pain community expressed concern after CVS pharmacy announced this month that it will limit opioid prescriptions to seven days for acute or new conditions. The wording of the new policy is as follows: “This program will include limiting to seven days the supply of opioids dispensed for certain acute prescriptions for patients who are new to therapy,” which means people living with chronic pain should not be subjected to the seven-day limit. However, CVS will limit the daily dosage of opioids and will require use of immediate-release formulations before prescribing extended-release opioids; these two changes may affect chronic pain patients.
“A number of states, including Massachusetts, have adopted laws limiting first-time opioid prescription to seven days, and this part of the new CVS policy is consistent with these restrictions” adds Cindy Steinberg, U.S. Pain’s national director of Policy and Advocacy. “We are in agreement with this limit for new, acute conditions; however instituting dosage limits for all patients is troubling. At the end of the day, we just want to make sure chronic pain patients aren’t facing unnecessary, unfair roadblocks to pain relief.”
CVS pharmacy locations also will increase education for patients filling an opioid prescription, expand its drug disposal collection program, and invest $2 million in addiction treatment.
“We are 100 percent supportive of more education and increased efforts to prevent diversion,” says Gileno. “We are encouraged that CVS is including these steps in their new policy, and hope to be part of a larger discussion on how to ensure patients with pain are protected too. We have a lot of ideas for ways to safely and fairly address the opioid crisis, from increasing the availability of abuse-deterrent formularies to legalizing medical cannabis. We just need someone to listen.”
To read U.S. Pain’s full position statement on opioids and balancing reform with pain management, click here.
“We are on board with limiting new prescriptions for acute pain, but we do believe there should be a specific, written exemption for chronic pain, palliative pain, and cancer pain in order to ensure they are protected,” says Paul Gileno, founder and president of U.S. Pain Foundation. “We agree that certain changes are necessary to end the opioid crisis, but we need to approach it in a way that considers the needs of chronic pain patients.”He went on to address the dosage limit. “We are weary of a pharmacy entity, rather than a doctor, determining the dosage of an individual’s pain medication. Everyone is different–their body chemistries and weights, their level of pain, reaction to pain and so on and these can affect how much medication they need. That specific type of decision should be left in the hands of clinicians.”
“A number of states, including Massachusetts, have adopted laws limiting first-time opioid prescription to seven days, and this part of the new CVS policy is consistent with these restrictions” adds Cindy Steinberg, U.S. Pain’s national director of Policy and Advocacy. “We are in agreement with this limit for new, acute conditions; however instituting dosage limits for all patients is troubling. At the end of the day, we just want to make sure chronic pain patients aren’t facing unnecessary, unfair roadblocks to pain relief.”
CVS pharmacy locations also will increase education for patients filling an opioid prescription, expand its drug disposal collection program, and invest $2 million in addiction treatment.
“We are 100 percent supportive of more education and increased efforts to prevent diversion,” says Gileno. “We are encouraged that CVS is including these steps in their new policy, and hope to be part of a larger discussion on how to ensure patients with pain are protected too. We have a lot of ideas for ways to safely and fairly address the opioid crisis, from increasing the availability of abuse-deterrent formularies to legalizing medical cannabis. We just need someone to listen.”
To read U.S. Pain’s full position statement on opioids and balancing reform with pain management, click here.
Source: U.S. Pain Foundation
Friday, September 22, 2017
Dr. Roberto A. Fernandez of Miami Sentenced for Role in Pain Pill Diversion and $4.8 Million Medicare Fraud Scheme
Sept. 20, 2017 - A Miami physician was sentenced today to 97 months in prison and three years of supervised release, for his role in a $4.8 million health care fraud scheme that involved the submission of false and fraudulent claims to Medicare and the illegal prescribing of controlled substances, including oxycodone and hydrocodone.
Acting Assistant Attorney General Kenneth A. Blanco of the Justice Department’s Criminal Division, Acting U.S. Attorney Benjamin G. Greenberg of the Southern District of Florida, Special Agent in Charge George L. Piro of the FBI’s Miami Field Office, Special Agent in Charge Shimon R. Richmond of the U.S. Department of Health and Human Services Office of Inspector General’s (HHS-OIG) Miami Regional Office and Special Agent in Charge Brian Swain of the U.S. Secret Service’s (USSS) Miami Field Office made the announcement.
Roberto A. Fernandez, M.D., 51, of Miami, was sentenced by U.S. District Judge Cecelia M. Altonaga of the Southern District of Florida. Judge Altonaga also ordered Fernandez to pay $4.8 million in restitution, jointly and severally with his co-conspirators. Fernandez pleaded guilty on July 11, to one count of conspiracy to commit health care fraud and wire fraud in connection with a scheme, that ran from April 2011 to February 2017, involving the submission of false and fraudulent claims to Medicare and the illegal prescribing of controlled substances, including oxycodone, hydrocodone and alprazolam.
As part of his guilty plea, Fernandez admitted that he referred Medicare beneficiaries to pharmacy owners in exchange for illegal health care kickbacks. Fernandez admitted knowing that the pharmacy owners were billing and receiving reimbursements from Medicare for prescription drugs based upon the prescriptions he sold, and that many of his prescriptions were medically unnecessary. For example, he admitted providing prescriptions for expensive, name brand drugs, including HIV/AIDS medications that conflicted with other HIV drugs already prescribed to the beneficiaries.
Fernandez also solicited referrals of Medicare beneficiaries to his own practices from his co-conspirators, he admitted, including submitting claims to Medicare under his Part B provider number for services he did not, in fact, render. Additionally, Fernandez admitted to receiving kickbacks in return for signing plans of care and prescriptions for medically unnecessary home health services.
Fernandez further admitted that he prescribed controlled substances, including addictive opioids, to patients and patient recruiters in return for $100 to $200 cash per prescription. Fernandez admitted that he knew these patients did not need the controlled substances he prescribed, and that he would sometimes write prescriptions for controlled substances for patients whom he did not even examine.
The FBI, HHS-OIG and USSS investigated the case, which was brought as part of the Medicare Fraud Strike Force, supervised by the Criminal Division’s Fraud Section and the U.S. Attorney’s Office for the Southern District of Florida. Assistant U.S. Attorney Lisa H. Miller of the Southern District of Florida and a former Fraud Section trial attorney, and Fraud Section Trial Attorney Adam G. Yoffie are prosecuting the case.
The Fraud Section leads the Medicare Fraud Strike Force, which is part of a joint initiative between the Department of Justice and HHS to focus their efforts to prevent and deter fraud and enforce current anti-fraud laws around the country. The Medicare Fraud Strike Force operates in nine locations nationwide. Since its inception in March 2007, the Medicare Fraud Strike Force has charged over 3,500 defendants who collectively have falsely billed the Medicare program for over $12.5 billion.
source: press release Department of Justice
Thursday, September 21, 2017
Fund More Research for Medical Marijuana as a Solution to the Opioid Crisis - Online Petition
There’s a petition taking off on Change.org, and I think you might be interested in signing it, I did. Jim
| Petitioning National Institutes of Health |
| National Institutes of Health: Fund More Research for Medical Marijuana as a Solution to the Opioid Crisis |
| ||||||||||
CDC Opioid Guidelines Violate Standards Of Science Research
If you follow healthcare news, you know that millions of US pain patients are experiencing a world of troubles. If their pain itself wasn’t enough, the US Centers for Disease Control and Prevention added to their agony in March 2016 by issuing a restrictive “Guideline” to primary care physicians on prescription of opioid medications to adults with long-lasting non-cancer pain.
American Council on Science and Health
American Council on Science and Health
article by Richard "Red" Lawhern , published by March 25, 2017
The Guideline was phrased as advisory rather than mandatory. But that distinction quickly got lost as the US Drug Enforcement Administration ramped up disciplinary proceedings and prosecution of doctors for “over-prescribing” opioids like OxyContin and hydrocodone. Even before final publication, Congress made the Guideline mandatory for the Department of Veterans Affairs. More recently, the US Centers for Medicare and Medicaid Services are seeking to turn the Guideline into a mandatory restrictive practice standard for insurance reimbursement.
The new CMS standard will impose legal limits on the maximum amount of opioid pain relievers that a doctor may prescribe to a patient who isn’t actually dying of cancer. A maximum of 90 Morphine Milligram Equivalents per Day (MMED) will be imposed retroactively on patients who have done well on much higher doses for years, with no evidence of addiction or overdose risk. This despite the fact that the methodology of MMED is itself considered a meaningless medical mythology by many experts in the field.
Consequences of these changes are predictable. Even more physicians will leave pain management practice, throwing thousands of patients into the street without medical referral or support when they go into opioid withdrawal. Whole areas of US States are already no longer served by any pain management center. Potentially millions more patients will be forcibly tapered down or cut off cold-turkey, plunging them into agony and disability when they can no longer work or maintain family relationships due to under-treatment of their pain. More patients will be turned away by emergency rooms and family doctors. Suicide rates -- already on the increase -- will soar.
A deceptive bureaucratic maze adds deep insult and possibly criminal intent to this obvious injury.
Many of the core assumptions of the CDC guidelines are supported by only the weakest medical evidence – and others are clearly contradicted by the evidence. Medical professionals have published sharp criticisms of the CDC guideline and of the anti-opioid biases of consultants who wrote the document. A recent paper in Pain Medicine[ref: Pain Med (2016) 17 (11): 2036-2046] offers analysis that shows the writers of the Guideline deliberatelydistorted the evidence they gathered.
CDC consultants performed a literature review on the effectiveness and risks of three classes of treatments for severe chronic pain: opioids, non-opioid medicines like Tylenol, and behavioral therapies like rational cognitive therapy. Based on this review, they declared that there is very little evidence that opioids work for pain over long periods of time. But they neglected to inform readers that they had rejected any study of opioid medications that hadn’t lasted at least a year, then declaring that there was no proof that opioids are effective over the long term. But they did NOT reject studies of non-opioid medications or behavioral therapies that were similarly short.
As the Pain Medicine paper states, “To dismiss trials as “inadequate” if their observation period is a year or less is inconsistent with current regulatory standards… Considering only duration of active treatment in efficacy or effectiveness trials, published evidence is no stronger for any major drug category or behavioral therapy than for opioids.”
This didn’t keep the writers of the CDC Guideline from recommending that non-opioid treatments be favored over opioids, despite lack of evidence that they work. Nor did it keep the writers from exaggerating opioid risks – using the term “overdose” no less than 150 times in their biased and unscientific practice standard.
It is time for the CDC to withdraw its misdirected “opioid guideline” for a major rewrite. This time, the effort should be led by pain management specialists, not addiction psychiatrists. Pain patients or their advocates should be voting members of the writers group.
================
An expanded version of this article was published on March 15, 2017 after collaboration with Dr. Lawhern, under the byline of Frank Carroll in the Custer County Chronicle (SD), titled “Opioid Guideline Needs a Rewrite”.
https://www.acsh.org/news/2017/03/25/cdc-opioid-guidelines-violate-standards-science-research-11050
The new CMS standard will impose legal limits on the maximum amount of opioid pain relievers that a doctor may prescribe to a patient who isn’t actually dying of cancer. A maximum of 90 Morphine Milligram Equivalents per Day (MMED) will be imposed retroactively on patients who have done well on much higher doses for years, with no evidence of addiction or overdose risk. This despite the fact that the methodology of MMED is itself considered a meaningless medical mythology by many experts in the field.
Consequences of these changes are predictable. Even more physicians will leave pain management practice, throwing thousands of patients into the street without medical referral or support when they go into opioid withdrawal. Whole areas of US States are already no longer served by any pain management center. Potentially millions more patients will be forcibly tapered down or cut off cold-turkey, plunging them into agony and disability when they can no longer work or maintain family relationships due to under-treatment of their pain. More patients will be turned away by emergency rooms and family doctors. Suicide rates -- already on the increase -- will soar.
A deceptive bureaucratic maze adds deep insult and possibly criminal intent to this obvious injury.
Many of the core assumptions of the CDC guidelines are supported by only the weakest medical evidence – and others are clearly contradicted by the evidence. Medical professionals have published sharp criticisms of the CDC guideline and of the anti-opioid biases of consultants who wrote the document. A recent paper in Pain Medicine[ref: Pain Med (2016) 17 (11): 2036-2046] offers analysis that shows the writers of the Guideline deliberatelydistorted the evidence they gathered.
CDC consultants performed a literature review on the effectiveness and risks of three classes of treatments for severe chronic pain: opioids, non-opioid medicines like Tylenol, and behavioral therapies like rational cognitive therapy. Based on this review, they declared that there is very little evidence that opioids work for pain over long periods of time. But they neglected to inform readers that they had rejected any study of opioid medications that hadn’t lasted at least a year, then declaring that there was no proof that opioids are effective over the long term. But they did NOT reject studies of non-opioid medications or behavioral therapies that were similarly short.
As the Pain Medicine paper states, “To dismiss trials as “inadequate” if their observation period is a year or less is inconsistent with current regulatory standards… Considering only duration of active treatment in efficacy or effectiveness trials, published evidence is no stronger for any major drug category or behavioral therapy than for opioids.”
This didn’t keep the writers of the CDC Guideline from recommending that non-opioid treatments be favored over opioids, despite lack of evidence that they work. Nor did it keep the writers from exaggerating opioid risks – using the term “overdose” no less than 150 times in their biased and unscientific practice standard.
It is time for the CDC to withdraw its misdirected “opioid guideline” for a major rewrite. This time, the effort should be led by pain management specialists, not addiction psychiatrists. Pain patients or their advocates should be voting members of the writers group.
================
An expanded version of this article was published on March 15, 2017 after collaboration with Dr. Lawhern, under the byline of Frank Carroll in the Custer County Chronicle (SD), titled “Opioid Guideline Needs a Rewrite”.
https://www.acsh.org/news/2017/03/25/cdc-opioid-guidelines-violate-standards-science-research-11050
Related articles
- Opioid Malfeasance At The CDC- Guess Who Is Getting Hurt?
- Searching for Alternatives to Opioids -Way Too Late
- Pain In The Time Of Opioid Denial: An Interview With Aric Hausknecht, M.D.
- In Search of Sane Pain Policies: An Interview With Richard Lawhern, Ph.D.
- Doctors and Legislators: Listen to Patients, Not the CDC
Friday, June 9, 2017
What is worse, the Opioid Epidemic or the Stupidity Epidemic?
When the National Institutes of Health announced recently that it is launching a joint initiative with pharmaceutical companies to spur the development of drugs to address the opioid epidemic, the National Pain Report reached out to an occasional contributor to the National Pain Report, Dr. Jay Joshi. Dr. Joshi is CEO/Medical Director – National Pain Centers in the Chicago area.
Wednesday, June 7, 2017
Why Chronic Pain Patients Say Opioid Crackdown Is Hurting Their Medical Care
Jim Watkins, 59, a longtime chronic-pain patient from Chicago, said he has been made to feel like a criminal at the doctor’s office in recent years because of his opioid pain prescription.
article by John Keilman for the Chicago Tribune | June 5, 2017
He has been on the drug for nearly two decades, and for almost all of that time, his doctors gave it to him without any problems. But over the last few years, he said, that has changed.
Watkins, a 59-year-old Chicagoan, is required to come in monthly to receive his prescription — he used to go as long as three months between visits — and each time, he said, he undergoes questioning about his opioid use that he regards as just short of harassment.
"(Chronic pain patients) are being singled out on a daily basis for something that other people have abused," he said. "Those of us who have legitimate conditions, why are we being treated differently?"
Americans' use of opioid painkillers has exploded since the mid-1990s, driven by changing philosophies on pain treatment, drug company marketing campaigns and unscrupulous "pill mill" operators. The result, many experts say, has been a surge in addiction, overdoses and death.
Now, a reversal is underway. Opioid prescriptions have dropped sharply since 2012 as doctors have grown more conservative and the federal government has cracked down on what it deems "problematic prescribing." But some chronic pain patients say the turnabout has gone too far.
They describe unwarranted dosage cuts from doctors and unprovoked suspicion from neighborhood pharmacists. And even those who have good relationships with their health care providers say they feel more and more that society views them as junkies, not patients.
"I don't advertise the fact that I take these medications just because of the way people look on it, like I'm a drug addict," said a 59-year-old Lincolnwood woman who takes oxymorphone for back pain. "You mention it to someone, and it's like, 'Oh, you're going to die; my cousin's neighbor's son died.' They start connecting it with heroin abuse."
But some believe the correction is long overdue. Dr. Andrew Kolodny of the Opioid Policy Research Collaborative at Brandeis University said the drugs have ill-served many people they were meant to help, condemning them to addiction while leaving their pain undiminished — or, in some cases, even worse.
"They're stuck on these medicines they feel they can't live without, and many of them may be right," he said. "The trick is not to get more people stuck on opioids."
Prized medicine
Opioids inhibit pain signals traveling to the brain, and that trait has made them a prized medicine for thousands of years. But their addictive properties made many doctors hesitant to prescribe them for chronic conditions, said Theodore Cicero, a professor of psychiatry at Washington University in St. Louis.
"You were given aspirin," he said. "The attitude was that you just have to put up with (pain)."
That changed in the 1990s after some medical organizations concluded that doctors were not adequately treating their patients' pain. They created new standards that portrayed pain as "the fifth vital sign," encouraging doctors to use more powerful medications in the name of compassionate care.
Another game-changer was the 1996 introduction of OxyContin, a powerful, time-release opioid aimed at patients with long-lasting pain. Drug company Purdue Pharma mounted a huge marketing campaign portraying the drug as less prone to misuse than other opioids.
That claim was false, as the company later admitted in a fraud settlement with the federal government. Drug abusers simply crushed the pills to unleash their full potency, and OxyContin swiftly became a leading product offered by shady medical clinics proliferating around the country.
"There were more than 1,000 pain clinics operating just in Florida around 2011," said John Temple, a West Virginia University journalism professor whose book, "American Pain," chronicles the rise and fall of a crooked clinic. "They were all churning out these prescriptions every day. I would say the vast majority were not for legitimate patients but for people who just walked in off the street."
OxyContin wasn't the only painkiller to soak into American culture: Overall opioid prescriptions more than doubled over 20 years, from 112 million in 1992 to 282 million in 2012, while per-capita consumption more than quintupled.
As the pills flooded into medicine cabinets, overdose deaths soared, according to the U.S. Centers for Disease Control and Prevention. While many fatalities were because of abuse, Kolodny said some studies suggest the majority came from valid prescriptions.
The grim statistics caused many to rethink pain treatment. The CDC released guidelines advising doctors to be more cautious when prescribing opioids. The Drug Enforcement Administration tightened the rules for hydrocodone, one of America's most frequently prescribed medications.
Meanwhile, the American College of Physicians declared that doctors should consider opioids a "last option" for the treatment of lower back pain, while the U.S. Departments of Veterans Affairs and Defense recommended against prescribing the drugs for chronic pain.
If those messages weren't loud enough, physicians could also consider the high-profile arrests of colleagues accused of indiscriminate opioid distribution.
"You're not dealing with normal drug dealers in this situation — you're dealing with doctors who have something to lose," Temple said. "If they see another doctor being led away in handcuffs, that has a big impact."
Insurance hassles
But Judith Paice, an advanced practice nurse who writes prescriptions for her work with cancer patients at Northwestern Medicine, said it's not fear of the law that is steering medical professionals away from opioids — it's fear of insurance companies.
Private insurers and the state's Medicaid program are increasingly requiring prior authorization for opioid medications, she said, and the hassle of those restrictions has convinced some to steer clear of the drugs altogether.
"Many practices are saying, 'I'm not going to prescribe opioids — it's not worth it because of the time and personnel constraints,'" said Paice, past president of the American Pain Society.
Experts say patients on long-standing opioid regimens sometimes get "fired" by their doctors out of concern they might be abusing the medication. A 47-year-old Chicago woman said that has happened to her repeatedly.
She said she has dealt with crippling back pain since trying to work through a slip-and-fall injury she suffered in her 20s, when she was a cocktail waitress on a riverboat casino. She has spent much of the last two decades on one opioid or another.
She said three doctors have dropped her for vague reasons or no reason at all, including one just last year. The clinic she now attends has a strict daily limit on the amount of opioids it allows patients to have, and she said her new regimen does not adequately treat her pain.
"We walk on eggshells with our doctors," said the woman, who asked to remain nameless for fear of being dropped again. "We're afraid of being labeled, blacklisted. It happens to a lot of people."
Bad choice?
Some doctors say that even without abuse worries, opioids are a bad choice for chronic pain. Kolodny said patients' suffering can be exacerbated by withdrawal symptoms, while other researchers have found that people on high doses of painkillers can become more sensitive to pain — a phenomenon known as hyperalgesia.
Dr. Asokumar Buvanendran, a pain specialist at Rush University Medical Center and president of the American Society of Regional Anesthesia and Pain Medicine, said therapies such as epidural injections, biofeedback and even acupuncture have proved to be equally or more effective at pain relief than opioids.
"Large studies have shown that over a year's time, it makes no difference whether you take narcotics or not," he said.
He noted, however, that alternative treatments often are not covered by insurance companies. That has left chronic pain sufferers like Paula Gianfortune reliant on opioids.
Gianfortune, 50, of Oak Brook, said she injured her neck in two accidents, and the ferocious pain that followed has caused her to be on opioids for about 14 years. She wears a patch that supplies a steady flow of fentanyl, and takes hydromorphone pills when her pain spikes.
She said she would like to try nonmedicinal therapies but can't afford the 20 percent copay required by her insurance policy. In the meantime, she said, she lives in fear that her doctors will decide unilaterally to cut her dosage or take away the medication altogether.
"Hurting people who need (opioids) to survive day to day is just so wrong," she said. "You're going to have people who are truly in pain resorting to doing illegal drugs, and good people will overdose and die. You're going to be so desperate to get rid of the pain somehow."
jkeilman@chicagotribune.com
http://www.chicagotribune.com/lifestyles/health/ct-opioid-patients-backlash-met-20170603-story.html Copyright © 2017, Chicago Tribune
Watkins, a 59-year-old Chicagoan, is required to come in monthly to receive his prescription — he used to go as long as three months between visits — and each time, he said, he undergoes questioning about his opioid use that he regards as just short of harassment.
"(Chronic pain patients) are being singled out on a daily basis for something that other people have abused," he said. "Those of us who have legitimate conditions, why are we being treated differently?"
Americans' use of opioid painkillers has exploded since the mid-1990s, driven by changing philosophies on pain treatment, drug company marketing campaigns and unscrupulous "pill mill" operators. The result, many experts say, has been a surge in addiction, overdoses and death.
Now, a reversal is underway. Opioid prescriptions have dropped sharply since 2012 as doctors have grown more conservative and the federal government has cracked down on what it deems "problematic prescribing." But some chronic pain patients say the turnabout has gone too far.
They describe unwarranted dosage cuts from doctors and unprovoked suspicion from neighborhood pharmacists. And even those who have good relationships with their health care providers say they feel more and more that society views them as junkies, not patients.
"I don't advertise the fact that I take these medications just because of the way people look on it, like I'm a drug addict," said a 59-year-old Lincolnwood woman who takes oxymorphone for back pain. "You mention it to someone, and it's like, 'Oh, you're going to die; my cousin's neighbor's son died.' They start connecting it with heroin abuse."
But some believe the correction is long overdue. Dr. Andrew Kolodny of the Opioid Policy Research Collaborative at Brandeis University said the drugs have ill-served many people they were meant to help, condemning them to addiction while leaving their pain undiminished — or, in some cases, even worse.
"They're stuck on these medicines they feel they can't live without, and many of them may be right," he said. "The trick is not to get more people stuck on opioids."
Prized medicine
Opioids inhibit pain signals traveling to the brain, and that trait has made them a prized medicine for thousands of years. But their addictive properties made many doctors hesitant to prescribe them for chronic conditions, said Theodore Cicero, a professor of psychiatry at Washington University in St. Louis.
"You were given aspirin," he said. "The attitude was that you just have to put up with (pain)."
That changed in the 1990s after some medical organizations concluded that doctors were not adequately treating their patients' pain. They created new standards that portrayed pain as "the fifth vital sign," encouraging doctors to use more powerful medications in the name of compassionate care.
Another game-changer was the 1996 introduction of OxyContin, a powerful, time-release opioid aimed at patients with long-lasting pain. Drug company Purdue Pharma mounted a huge marketing campaign portraying the drug as less prone to misuse than other opioids.
That claim was false, as the company later admitted in a fraud settlement with the federal government. Drug abusers simply crushed the pills to unleash their full potency, and OxyContin swiftly became a leading product offered by shady medical clinics proliferating around the country.
"There were more than 1,000 pain clinics operating just in Florida around 2011," said John Temple, a West Virginia University journalism professor whose book, "American Pain," chronicles the rise and fall of a crooked clinic. "They were all churning out these prescriptions every day. I would say the vast majority were not for legitimate patients but for people who just walked in off the street."
OxyContin wasn't the only painkiller to soak into American culture: Overall opioid prescriptions more than doubled over 20 years, from 112 million in 1992 to 282 million in 2012, while per-capita consumption more than quintupled.
As the pills flooded into medicine cabinets, overdose deaths soared, according to the U.S. Centers for Disease Control and Prevention. While many fatalities were because of abuse, Kolodny said some studies suggest the majority came from valid prescriptions.
The grim statistics caused many to rethink pain treatment. The CDC released guidelines advising doctors to be more cautious when prescribing opioids. The Drug Enforcement Administration tightened the rules for hydrocodone, one of America's most frequently prescribed medications.
Meanwhile, the American College of Physicians declared that doctors should consider opioids a "last option" for the treatment of lower back pain, while the U.S. Departments of Veterans Affairs and Defense recommended against prescribing the drugs for chronic pain.
If those messages weren't loud enough, physicians could also consider the high-profile arrests of colleagues accused of indiscriminate opioid distribution.
"You're not dealing with normal drug dealers in this situation — you're dealing with doctors who have something to lose," Temple said. "If they see another doctor being led away in handcuffs, that has a big impact."
Insurance hassles
But Judith Paice, an advanced practice nurse who writes prescriptions for her work with cancer patients at Northwestern Medicine, said it's not fear of the law that is steering medical professionals away from opioids — it's fear of insurance companies.
Private insurers and the state's Medicaid program are increasingly requiring prior authorization for opioid medications, she said, and the hassle of those restrictions has convinced some to steer clear of the drugs altogether.
"Many practices are saying, 'I'm not going to prescribe opioids — it's not worth it because of the time and personnel constraints,'" said Paice, past president of the American Pain Society.
Experts say patients on long-standing opioid regimens sometimes get "fired" by their doctors out of concern they might be abusing the medication. A 47-year-old Chicago woman said that has happened to her repeatedly.
She said she has dealt with crippling back pain since trying to work through a slip-and-fall injury she suffered in her 20s, when she was a cocktail waitress on a riverboat casino. She has spent much of the last two decades on one opioid or another.
She said three doctors have dropped her for vague reasons or no reason at all, including one just last year. The clinic she now attends has a strict daily limit on the amount of opioids it allows patients to have, and she said her new regimen does not adequately treat her pain.
"We walk on eggshells with our doctors," said the woman, who asked to remain nameless for fear of being dropped again. "We're afraid of being labeled, blacklisted. It happens to a lot of people."
Bad choice?
Some doctors say that even without abuse worries, opioids are a bad choice for chronic pain. Kolodny said patients' suffering can be exacerbated by withdrawal symptoms, while other researchers have found that people on high doses of painkillers can become more sensitive to pain — a phenomenon known as hyperalgesia.
Dr. Asokumar Buvanendran, a pain specialist at Rush University Medical Center and president of the American Society of Regional Anesthesia and Pain Medicine, said therapies such as epidural injections, biofeedback and even acupuncture have proved to be equally or more effective at pain relief than opioids.
"Large studies have shown that over a year's time, it makes no difference whether you take narcotics or not," he said.
He noted, however, that alternative treatments often are not covered by insurance companies. That has left chronic pain sufferers like Paula Gianfortune reliant on opioids.
Gianfortune, 50, of Oak Brook, said she injured her neck in two accidents, and the ferocious pain that followed has caused her to be on opioids for about 14 years. She wears a patch that supplies a steady flow of fentanyl, and takes hydromorphone pills when her pain spikes.
She said she would like to try nonmedicinal therapies but can't afford the 20 percent copay required by her insurance policy. In the meantime, she said, she lives in fear that her doctors will decide unilaterally to cut her dosage or take away the medication altogether.
"Hurting people who need (opioids) to survive day to day is just so wrong," she said. "You're going to have people who are truly in pain resorting to doing illegal drugs, and good people will overdose and die. You're going to be so desperate to get rid of the pain somehow."
jkeilman@chicagotribune.com
http://www.chicagotribune.com/lifestyles/health/ct-opioid-patients-backlash-met-20170603-story.html Copyright © 2017, Chicago Tribune
Monday, May 15, 2017
Drug Use by State Report: 2017’s Problem Areas
May 15, 2017 - With the White House sending mixed messages about how it plans to deal with drug abuse, establishing a commission to study the Opioid epidemic yet proposing to cut the Office of National Drug Control Policy’s budget by 95%, the personal-finance website WalletHub today released a study on the States with the Biggest Drug Problems in 2017 to highlight the areas that stand to be most affected.
This study compares the 50 states and the District in terms of 15 key metrics, ranging from arrest and overdose rates to Opioid prescriptions and meth-lab incidents per capita. You can find some highlights below.
Key Stats:
To view the full report and learn about drug abuse in your state, please visit:
https://wallethub.com/edu/ drug-use-by-state/35150/
source: WalletHub May 15, 2017
# # #
Editors note:The report mentions the White House commission on Opioid epidemic. I am concerned of the lack of Chronic Pain Patients being acknowledged and excluded for the purpose of the report, and in the report synopsis. Jim W.
This study compares the 50 states and the District in terms of 15 key metrics, ranging from arrest and overdose rates to Opioid prescriptions and meth-lab incidents per capita. You can find some highlights below.
| States with the Biggest Drug Problems | ||||
| 1 | District of Columbia | 11 | New Hampshire | |
| 2 | Vermont | 12 | West Virginia | |
| 3 | Colorado | 13 | New York | |
| 4 | Delaware | 14 | Indiana | |
| 5 | Rhode Island | 15 | Louisiana | |
| 6 | Oregon | 16 | Missouri | |
| 7 | Connecticut | 17 | Maine | |
| 8 | Arizona | 18 | Maryland | |
| 9 | Massachusetts | 19 | Washington | |
| 10 | Michigan | 20 | North Carolina | |
Key Stats:
- Alabama has 142.9 opioid pain reliever prescriptions for every 100 residents, leading the nation. On the other end of the spectrum, there are 52.0 opioid prescriptions for every 100 Hawaiians.
- West Virginia has 42 drug overdose deaths for every 100,000 residents. That is six times more than Nebraska, which has the fewest overdose deaths, at 7 per 100,000 residents.
- Colorado has the highest percentage of teens who used illicit drugs in the past month, at 14.58 percent. That is 2.5 times higher than in Iowa, which has the lowest rate (6.31 percent).
- New Jersey has the highest percentage of teens who have been offered, sold or given an illegal drug on school property, at 30.70 percent. That is 2.6 times higher than in Iowa (11.90 percent), the state with the lowest rate.
- Colorado has the highest percentage of adults who used illicit drugs in the past month, at 17.06 percent, topping South Dakota’s low (5.76 percent) by 2.8 times.
- At 16.50 percent, the percentage of New Mexico teens who tried marijuana before age 13 is 4.3 times higher than in Utah (3.70 percent), where teens are least likely to do so.
- Nearly 9 out of every 1,000 South Dakotans have been arrested for a drug violation, which is the country’s highest rate. Vermont, at the low end, has just over 1 drug arrest per 1,000 residents.
- The District of Columbia has the highest percentage of adults who needed but didn’t receive treatment for illicit drug use in the past year, at 3.21 percent. That is 1.5 times higher than in Wyoming (1.83 percent), which has the lowest rate.
To view the full report and learn about drug abuse in your state, please visit:
https://wallethub.com/edu/
source: WalletHub May 15, 2017
# # #
Editors note:The report mentions the White House commission on Opioid epidemic. I am concerned of the lack of Chronic Pain Patients being acknowledged and excluded for the purpose of the report, and in the report synopsis. Jim W.
Monday, August 8, 2016
Please Support For The "National Pain Strategy (NPS)", Online Petition open til Aug 12th
As one of many Americans who suffer from pain on daily basis, please consider supporting and signing the online petition in support of, and funding of for a National Pain Strategy!
Jim at Ability Chicago Info
# # #
from a Press Release from the National Pain Report | Aug. 8, 2016
100 Million Americans Need 3 Seconds of Your Time
At the National Pain Report, we often leave the opinion making to folks who are advocates for any number of issues. And, it’s our position to allow those varying points of view on our site – it’s part of our mission.
We will exercise our privilege in expressing our own opinion by saying, you should sign this petition to fund the National Pain Strategy (NPS). The deadline is Friday August 12!
It’s simple. Click on the button, enter your name and email address, and then verify your email. It takes seconds.
We need 90,000 people to sign the petition this week, so please forward this email to your family and friends and ask then to act.
Here’s a Little Backdrop:
While the debate about chronic pain treatment has been dominated this year by the CDC and its Opioid Prescribing Guideline, it is in truth a small part of the chronic pain treatment story. The much – or at least more important – issue should be how the government can implement the country’s first strategic plan to achieve a system of safe, effective and high-quality pain care informed by science.
Read the National Pain Strategy
We have been frustrated by the inaction by the National Institutes of Health on the NPS since it was introduced with very little fanfare by the National Institutes of Health. If research, healthcare provider training, insurance coverage issues and public awareness of pain are going to be addressed, the NPS is, quite simply, the best vehicle for a comprehensive approach.
The petition, which is supported by most pain advocacy organizations, directs the Obama Administration to direct the Health and Human Services agency to swiftly fund and implement the NPS.
Developed by a diverse team of experts from around the nation, the National Pain Strategy is a roadmap toward achieving a system of care in which all people receive appropriate, high quality and evidence-based care for pain.
We would argue that the government should use the NPS to stimulate a real debate about chronic pain and find solutions to the education, research and treatment issues that plague millions of Americans.
Sign the petition.
Copyright © 2016 www.NationalPainReport.com All rights reserved.
from a Press Release from the National Pain Report | Aug. 8, 2016
100 Million Americans Need 3 Seconds of Your Time
At the National Pain Report, we often leave the opinion making to folks who are advocates for any number of issues. And, it’s our position to allow those varying points of view on our site – it’s part of our mission.
We will exercise our privilege in expressing our own opinion by saying, you should sign this petition to fund the National Pain Strategy (NPS). The deadline is Friday August 12!
It’s simple. Click on the button, enter your name and email address, and then verify your email. It takes seconds.
We need 90,000 people to sign the petition this week, so please forward this email to your family and friends and ask then to act.
Here’s a Little Backdrop:
While the debate about chronic pain treatment has been dominated this year by the CDC and its Opioid Prescribing Guideline, it is in truth a small part of the chronic pain treatment story. The much – or at least more important – issue should be how the government can implement the country’s first strategic plan to achieve a system of safe, effective and high-quality pain care informed by science.
Read the National Pain Strategy
We have been frustrated by the inaction by the National Institutes of Health on the NPS since it was introduced with very little fanfare by the National Institutes of Health. If research, healthcare provider training, insurance coverage issues and public awareness of pain are going to be addressed, the NPS is, quite simply, the best vehicle for a comprehensive approach.
The petition, which is supported by most pain advocacy organizations, directs the Obama Administration to direct the Health and Human Services agency to swiftly fund and implement the NPS.
Developed by a diverse team of experts from around the nation, the National Pain Strategy is a roadmap toward achieving a system of care in which all people receive appropriate, high quality and evidence-based care for pain.
We would argue that the government should use the NPS to stimulate a real debate about chronic pain and find solutions to the education, research and treatment issues that plague millions of Americans.
Sign the petition.
Copyright © 2016 www.NationalPainReport.com All rights reserved.
Wednesday, April 6, 2016
U.S. Chronic Pain Patient To Be Heard? Take the 2016 National Survey!
The National Pain Report is requesting for those of us that live with Pain, participate in a national survey from the U.S. Pain Foundation.
U.S. Pain is collecting data to gain a sense of how much information is known about the CDC Guidelines for Prescribing Opioids for Chronic Pain, FDA Opioids Action Plan and the National Pain Strategy (NPS).
The voice of the chronic pain patient needs to be heard.
|
|
Tuesday, March 15, 2016
Overly protective CDC issues new guidelines on opiate prescribing to reduce abuse, overdoses
The Centers for Disease Control and Prevention warned doctors Tuesday to use caution when prescribing drugs for chronic pain and to carefully monitor patients using the medications, as part of an effort to reduce addiction and overdoses.
article by Liz Szabo for USA Today | March 15, 2016
The USA is in the grips of an epidemic of prescription painkiller abuse, with 40 Americans a day dying from overdoses, according to the CDC. In 2013, an estimated 1.9 million people abused or were dependent on prescription opiates, drugs in the same class as morphine.
Nearly all of the prescription opiates on the market are as powerful as heroin, said CDC director Thomas Frieden. Yet prescription opiates often do a very poor job in controlling chronic pain. Some patients who are prescribed opiates actually experience more pain than others, Frieden said. For the vast majority of patients with chronic pain, the risks aren't worth the benefits, he said.
"We know of no other medication used for non-fatal conditions that kills patients so frequently," Frieden said. "We hope to see fewer deaths from opiates. That's the bottom line. These are really dangerous medications that carry the risk of addiction and death."
The hard line on opiates is a major shift from conventional wisdom about relieving pain. For decades, doctors were told to consider pain as a vital sign that needed to be addressed.
The CDC's 12 news guidelines are intended for primary care physicians, who prescribe more than half of opiates.
The recommendations aim to help doctors determine when to begin or continue opiates for chronic pain; how to choose opiates and for how long; and how to value the risk and harms of opiates. The recommendations, which doctors aren't legally obligated to follow, don't apply to the treatment of patients being treated for cancer or those receiving palliative or end-of-life care.
When treating chronic pain, doctors should use therapies other than opiates first, such as exercise or non-steroidal anti-inflammatories, such as ibuprofen, Frieden said.
Doctors should only prescribe opiates when they expect the benefits to outweigh the risks. Before starting opiates, doctors should talk to patients about their treatment goals and when to stop using opiates. Doctors should avoid prescribing opiates, which include drugs such as Vicodin and OxyContin, at the same time as benzodiazepines, which include the anti-anxiety drugs Valium and Xanax.
When doctors do prescribe opiates, they should use the lowest effective dose for the shortest amount of time, Frieden said. Patients with acute pain, such as that caused by an injury, usually don't need prescription opiates more than three days. "When opiates are used, start low and go slow," Frieden said, meaning that doctors should increase the dose of medication slowly and only when really needed.
Doctors should check every three months to see if the benefits of opiates still outweigh the risks, according to the guidelines.
If patients abuse opiates, doctors should help them get treatment that's supported by strong medical evidence, such as the therapies buprenorphine or methadone, according to the guidelines.
Patients should ask questions if their doctors want to prescribe them opiates, said Deborah Dowell, senior medical adviser in the division of unintentional injury prevention at the CDC’s National Center for Injury Prevention and Control. Key questions to ask include: Is an opiate necessary? What are the risks? What are the benefits? How long should I take this? Are there alternatives? What we hope to accomplish by using an opiate? How will you know when we've met our goal?
The USA is in the grips of an epidemic of prescription painkiller abuse, with 40 Americans a day dying from overdoses, according to the CDC. In 2013, an estimated 1.9 million people abused or were dependent on prescription opiates, drugs in the same class as morphine.
Nearly all of the prescription opiates on the market are as powerful as heroin, said CDC director Thomas Frieden. Yet prescription opiates often do a very poor job in controlling chronic pain. Some patients who are prescribed opiates actually experience more pain than others, Frieden said. For the vast majority of patients with chronic pain, the risks aren't worth the benefits, he said.
"We know of no other medication used for non-fatal conditions that kills patients so frequently," Frieden said. "We hope to see fewer deaths from opiates. That's the bottom line. These are really dangerous medications that carry the risk of addiction and death."
The hard line on opiates is a major shift from conventional wisdom about relieving pain. For decades, doctors were told to consider pain as a vital sign that needed to be addressed.
The CDC's 12 news guidelines are intended for primary care physicians, who prescribe more than half of opiates.
The recommendations aim to help doctors determine when to begin or continue opiates for chronic pain; how to choose opiates and for how long; and how to value the risk and harms of opiates. The recommendations, which doctors aren't legally obligated to follow, don't apply to the treatment of patients being treated for cancer or those receiving palliative or end-of-life care.
When treating chronic pain, doctors should use therapies other than opiates first, such as exercise or non-steroidal anti-inflammatories, such as ibuprofen, Frieden said.
Doctors should only prescribe opiates when they expect the benefits to outweigh the risks. Before starting opiates, doctors should talk to patients about their treatment goals and when to stop using opiates. Doctors should avoid prescribing opiates, which include drugs such as Vicodin and OxyContin, at the same time as benzodiazepines, which include the anti-anxiety drugs Valium and Xanax.
When doctors do prescribe opiates, they should use the lowest effective dose for the shortest amount of time, Frieden said. Patients with acute pain, such as that caused by an injury, usually don't need prescription opiates more than three days. "When opiates are used, start low and go slow," Frieden said, meaning that doctors should increase the dose of medication slowly and only when really needed.
Doctors should check every three months to see if the benefits of opiates still outweigh the risks, according to the guidelines.
If patients abuse opiates, doctors should help them get treatment that's supported by strong medical evidence, such as the therapies buprenorphine or methadone, according to the guidelines.
Patients should ask questions if their doctors want to prescribe them opiates, said Deborah Dowell, senior medical adviser in the division of unintentional injury prevention at the CDC’s National Center for Injury Prevention and Control. Key questions to ask include: Is an opiate necessary? What are the risks? What are the benefits? How long should I take this? Are there alternatives? What we hope to accomplish by using an opiate? How will you know when we've met our goal?
http://www.msn.com/en-us/news/us/cdc-issues-new-guidelines-on-opiate-prescribing-to-reduce-abuse-overdoses/ar-BBquD8z?li=BBnb4R7&ocid=U148DHP
###
If medical professionals had been actual using common sense when prescribing medication to patients, would those of us that are able to live our lives with needed pain medications have to deal with now overly protective medical "professinal" now that are protecting there own asses now?...
Wednesday, February 24, 2016
Pain Sufferers Supported, President Obama Recognizes the Need for Opioids
Monday, in what seems like an unlikely decision in the current environment on the war on heroin and opioid painkiller addiction, President Obama recognized and supported the pain community when he declined to endorse a bipartisan recommendation that would limit the amount of opioid painkillers that a physician can prescribe.
National Pain Report - Feb 24, 2016 -- This past weekend the Nation’s governors met to discuss the most pressing items of the day, and among them was the rising problem of opioid painkiller and heroin addiction and overdose.
In a joint statement by National Governors Association (NGA) Health and Human Services Committee Chair Massachusetts Gov. Charlie Baker; Vice Chair New Hampshire Gov. Maggie Hassan; and American Medical Association (AMA) Chair-Elect Patrice A. Harris, MD, MA, the committee recommended guidelines to prevent the over-prescription of pain-killers, stating, “We agree that education about effective pain management, substance use disorder and related areas should begin in medical school and continue throughout a physician’s career. That means physicians who prescribe opioids and other controlled substances must be sure they have the most up-to-date training and education to prescribe and administer those substances safely and effectively. It is imperative we provide care for patients in pain. However, prescribing medications excessively or “just in case” is not acceptable and continues to fuel this growing epidemic. Guidelines are an important tool to prevent over-prescribing and identify the signs of addiction while meeting the needs of patients in pain. We must also ensure patient satisfaction surveys and accreditation standards are not contributing to the problem by encouraging unnecessary opioid prescribing.”
Gov. Peter Shumlin of Vermont, stated opioids “are passed out like candy in America,” noting that there are more than 250 million prescriptions a year for painkillers – enough for every American adult to have a bottle of pills.
The governors also recognized the difficultly in the challenge, “Reducing the opioid pill supply, for example, can have the unintended consequence of increasing heroin use. Laws aimed at unscrupulous providers can make ethical providers less willing to prescribe out of fear of scrutiny from law enforcement.”
While the President recognized the bipartisan support in addressing the nation’s addiction problem, he recognized the needs of pain sufferers, and suggested that action such as limiting the number of pain pills prescribed should be part of a more comprehensive approach.
“If we go to doctors right now and say ‘Don’t overprescribe’ without providing some mechanisms for people in these communities to deal with the pain that they have or the issues that they have, then we’re not going to solve the problem,” said the President, “because the pain is real, the mental illness is real.” He also recognized the need to address the needs of pain sufferers in rural American who may not have the means to afford more surgeries and/or more expensive treatments.
The President continued, “This is an area where I can get agreement from Bernie Sanders and Mitch McConnell. That doesn’t happen that often.”
For the National Pain Report, visit: http://nationalpainreport.com/
http://nationalpainreport.com/president-recognizes-the-need-for-opioids-for-pain-sufferers-8829652.html
# on a personnel note, this is a solid decision, Pain Management allows so many of us to live our lives daily. Jim at Ability Chicago Info
Friday, January 29, 2016
Traveling with Chronic Pain & CRPS, a traveler's story
I’m sitting in a chair by the Emirates Airline check-in counter waiting for my wheelchair. I hate waiting. I hate wheelchairs. And, I have always hated flying. I’m not afraid of flying – I just hate relinquishing control of my surroundings. Depending on other people is not something I’m very good at – but that’s exactly what is required of you when you travel by plane.
nice article by Katelyn O’Leary for The National Pain Report | January 28, 2016
Relinquishing control, however, is a lesson I’ve had to learn the hard way. After being diagnosed with Complex Regional Pain Syndrome (CRPS) due to having hip surgery in 2015, I have put my faith and my trust into the hands of doctors, physical therapists, specialists, radiologists, and nurses. Sometimes my faith has been rewarded, other times not so much.
CRPS is really just a fancy acronym for “We Don’t Know but We Will Sure Try.” And so – 12 medications, four full spine MRIs, a spinal tap, and three hospitalizations later – I have learned a hard lesson in trusting other people to do things for me while still being able to speak up for myself.
That being said, my condition has had serious ramifications on my self-esteem and my anxiety as it pertains to my surroundings. Sometimes I’m afraid to walk outside my apartment door, fearing my leg will cause me to stumble.
But, when I was invited to a wedding in India, I had to put my fear aside. I was not going to miss out on my friend’s big day, and I would be traveling with a group so what could go wrong?
Basically everything if I wasn’t careful.
Going to India was a massive undertaking for many reasons, including the fact that I had not been on an airplane since before my hip surgery. But, I booked my flights in June 2015. We would be flying out of Los Angeles on December, 28, 2015, landing in Dubai (after 16 hours of flight time) for an eight hour layover and then flying from Dubai to Mumbai the next morning (three hours of flight time).
The wedding was January 2nd, 2016, and I had exactly six months to get physically fit and cleared to fly. I wrongly assumed I would be much better by December, thinking I would fully recover. By August 2015, it was clear to me that I needed to re-think my recovery completely and instead focus on physical therapy and meeting with every specialist and doctor I have to discuss my medical options.
Traveling across the world would take two things: strengthening my leg, and the right cocktail of medications. I met with my neurologist, rheumatologist, physical therapist, my primary care physician, and my pain management specialist to determine what steps I needed to take both literally and figuratively.
I also contacted Emirates Airline to determine their policies for disabled travelers. I cannot stress this enough if you have a medical condition or disability, call the airline. Not only did Emirates place me in seats with more legroom, they also gave me a complimentary hotel room in Dubai during our eight hour layover so I could lie down and ice on a bed.
When I flew home for Thanksgiving, I used the flight from Los Angeles to Chicago as a trial run for my leg. I took meds to help me sleep and relax on the four hour flight. Just as we were preparing to land, I woke up and it felt like my leg was a hot dog in a microwave: nuked on high and ready to explode. My ankle was throbbing as if someone had taken my foot and twisted it as hard as they could. My calf muscle felt like someone replaced my tissue with hot wires. My thigh muscle was contracting so hard I could relate to the Hulk. And my hip was burning with pain. Fun fact about air travel for those with CRPS: the barometric pressure and / or cabin pressure can exacerbate nerve pain and make your pain 1000% worse. I leaned forward in my seat and grabbed my meds. By the time I met my family outside of O’Hare I was shaking with agony and needed to lie down in the back seat of my mother’s car with ice and a blanket.
If my pain was this bad on a four hour flight, how could I survive a 16-hour flight to Dubai? This was exactly what I needed to avoid. My neurologist prescribed me valium for the flights and the buses I would be taking in India. My rheumatologist helped me create a regimen of steroids (for swelling and inflammation) and pain meds. My primary care physician gave me the proper vaccinations and also prescribed me antibiotics in case I came down with a stomach bug. My physical therapist met with me weekly to help stretch, strengthen, and heal my leg as much as possible. But my pain management specialist? He told me in no uncertain terms that I should cancel my trip and stay home.
His reasoning wasn’t wrong. I was about to embark on a terribly long and arduous journey that would be hard on anyone – disability or no disability. But, I had something to prove. I had not worked for months towards this goal just to give up. Traveling to India wasn’t just about the wedding anymore: it was about returning to my life. It was about being 27 years old and wanting to see the world. It was about proving to myself that I can have a life outside my medical condition, if I was brave enough to try.
Ultimately, the 16 hour flights were the hardest legs of my trip. I made sure I had all of my medications, but I also wore my TENS unit for the entire flight. For those who don’t know, a TENS unit (Transcutaneous Electrical Nerve Stimulation) is a “device predominately used for nerve related pain conditions (acute and chronic).” A TENS unit works by sending stimulating pulses across the surface of the skin and along the nerve strands by attaching adhesive electrodes to the affected area (via tensunits.com). The TENS unit helped prevent swelling and flare ups in my leg due to the cabin pressure.
But the most important thing I had to do was stretch and move during the flights. Every two hours I would need to get up and walk down the aisles and stretch my body in the bathroom – which was extremely difficult since I’m over six feet tall and airplane bathrooms are tiny. Finally, I would request ice from the flight attendants every few hours and wrap my hip with it.
Waiting by the Emirates desk for my wheelchair, I didn’t know then what I know now – that I would have an incredible experience, and all of those months of preparation would serve me well, and that I could do it.
It wasn’t easy by any stretch of the imagination, I needed wheelchairs, crutches, ice, and a bag full of meds to make it, but with a little help from my friends and my amazing roommate who traveled with me, I was able to experience the wonders and beauty of India.
When I returned home from my trip, I realized I needed a new goal to invigorate me. There are many things I want to return to, such as being able to drive more than ten miles, my job and running. Lucky for me I have a team of doctors who, God-willing, can help me reach those goals.
Editor’s Note: Katelyn (Katie) O’Leary is a 27-year old Indiana native living in Los Angeles and working in the entertainment industry who developed CRPS after a sports injury in college. She writes for the National Pain Report.
nice article by Katelyn O’Leary for The National Pain Report | January 28, 2016
Relinquishing control, however, is a lesson I’ve had to learn the hard way. After being diagnosed with Complex Regional Pain Syndrome (CRPS) due to having hip surgery in 2015, I have put my faith and my trust into the hands of doctors, physical therapists, specialists, radiologists, and nurses. Sometimes my faith has been rewarded, other times not so much.
CRPS is really just a fancy acronym for “We Don’t Know but We Will Sure Try.” And so – 12 medications, four full spine MRIs, a spinal tap, and three hospitalizations later – I have learned a hard lesson in trusting other people to do things for me while still being able to speak up for myself.
That being said, my condition has had serious ramifications on my self-esteem and my anxiety as it pertains to my surroundings. Sometimes I’m afraid to walk outside my apartment door, fearing my leg will cause me to stumble.
But, when I was invited to a wedding in India, I had to put my fear aside. I was not going to miss out on my friend’s big day, and I would be traveling with a group so what could go wrong?
Basically everything if I wasn’t careful.
Going to India was a massive undertaking for many reasons, including the fact that I had not been on an airplane since before my hip surgery. But, I booked my flights in June 2015. We would be flying out of Los Angeles on December, 28, 2015, landing in Dubai (after 16 hours of flight time) for an eight hour layover and then flying from Dubai to Mumbai the next morning (three hours of flight time).
The wedding was January 2nd, 2016, and I had exactly six months to get physically fit and cleared to fly. I wrongly assumed I would be much better by December, thinking I would fully recover. By August 2015, it was clear to me that I needed to re-think my recovery completely and instead focus on physical therapy and meeting with every specialist and doctor I have to discuss my medical options.
Traveling across the world would take two things: strengthening my leg, and the right cocktail of medications. I met with my neurologist, rheumatologist, physical therapist, my primary care physician, and my pain management specialist to determine what steps I needed to take both literally and figuratively.
I also contacted Emirates Airline to determine their policies for disabled travelers. I cannot stress this enough if you have a medical condition or disability, call the airline. Not only did Emirates place me in seats with more legroom, they also gave me a complimentary hotel room in Dubai during our eight hour layover so I could lie down and ice on a bed.
When I flew home for Thanksgiving, I used the flight from Los Angeles to Chicago as a trial run for my leg. I took meds to help me sleep and relax on the four hour flight. Just as we were preparing to land, I woke up and it felt like my leg was a hot dog in a microwave: nuked on high and ready to explode. My ankle was throbbing as if someone had taken my foot and twisted it as hard as they could. My calf muscle felt like someone replaced my tissue with hot wires. My thigh muscle was contracting so hard I could relate to the Hulk. And my hip was burning with pain. Fun fact about air travel for those with CRPS: the barometric pressure and / or cabin pressure can exacerbate nerve pain and make your pain 1000% worse. I leaned forward in my seat and grabbed my meds. By the time I met my family outside of O’Hare I was shaking with agony and needed to lie down in the back seat of my mother’s car with ice and a blanket.
If my pain was this bad on a four hour flight, how could I survive a 16-hour flight to Dubai? This was exactly what I needed to avoid. My neurologist prescribed me valium for the flights and the buses I would be taking in India. My rheumatologist helped me create a regimen of steroids (for swelling and inflammation) and pain meds. My primary care physician gave me the proper vaccinations and also prescribed me antibiotics in case I came down with a stomach bug. My physical therapist met with me weekly to help stretch, strengthen, and heal my leg as much as possible. But my pain management specialist? He told me in no uncertain terms that I should cancel my trip and stay home.
His reasoning wasn’t wrong. I was about to embark on a terribly long and arduous journey that would be hard on anyone – disability or no disability. But, I had something to prove. I had not worked for months towards this goal just to give up. Traveling to India wasn’t just about the wedding anymore: it was about returning to my life. It was about being 27 years old and wanting to see the world. It was about proving to myself that I can have a life outside my medical condition, if I was brave enough to try.
Ultimately, the 16 hour flights were the hardest legs of my trip. I made sure I had all of my medications, but I also wore my TENS unit for the entire flight. For those who don’t know, a TENS unit (Transcutaneous Electrical Nerve Stimulation) is a “device predominately used for nerve related pain conditions (acute and chronic).” A TENS unit works by sending stimulating pulses across the surface of the skin and along the nerve strands by attaching adhesive electrodes to the affected area (via tensunits.com). The TENS unit helped prevent swelling and flare ups in my leg due to the cabin pressure.
But the most important thing I had to do was stretch and move during the flights. Every two hours I would need to get up and walk down the aisles and stretch my body in the bathroom – which was extremely difficult since I’m over six feet tall and airplane bathrooms are tiny. Finally, I would request ice from the flight attendants every few hours and wrap my hip with it.
Waiting by the Emirates desk for my wheelchair, I didn’t know then what I know now – that I would have an incredible experience, and all of those months of preparation would serve me well, and that I could do it.
It wasn’t easy by any stretch of the imagination, I needed wheelchairs, crutches, ice, and a bag full of meds to make it, but with a little help from my friends and my amazing roommate who traveled with me, I was able to experience the wonders and beauty of India.
When I returned home from my trip, I realized I needed a new goal to invigorate me. There are many things I want to return to, such as being able to drive more than ten miles, my job and running. Lucky for me I have a team of doctors who, God-willing, can help me reach those goals.
Editor’s Note: Katelyn (Katie) O’Leary is a 27-year old Indiana native living in Los Angeles and working in the entertainment industry who developed CRPS after a sports injury in college. She writes for the National Pain Report.
http://nationalpainreport.com/my-story-traveling-with-chronic-pain-crps-8829416.html
Thursday, July 2, 2015
Chronic Pain Patient Summit Set For Chicago Area - August 15, 2015
Chronic Pain Patient Summit Set For Chicago Area
as shared by the National Pain Report | July 1, 2015
An event scheduled near Chicago later this summer is designed to educate and empower chronic pain patients – and it’s free for patients.
The Midwest Pain Summit will review the latest in neuropathic pain treatment and education. It is sponsored by the Power of Pain Foundation, an increasingly influential patient advocate non-profit organization.
“It’s one of the events that we promote around the country each year for the benefit of people who suffer from pain and their loved ones,” said Barby Ingle who serves as the foundation’s president.
This is the second year that the Midwest event has been held.
“Living in the Midwest, I’ve been frustrated in the past that more events like this weren’t held in the middle of the country,” said Gracie Gean Bagosy-Young, a pain patient advocate and consultant who also serves on the executive council for Power of Pain.
“As a chronic pain patient I know the most important thing is having information that can help guide the care and treatment of an individual’s pain,” she said. “This event is designed to provide patients access to the latest in treatment modalities.”
Both Ingle and Bagosy suffer from chronic pain and have been active in empowering patients. Ingle, in addition to co-founding the foundation with her late sister, is a well-regarded author and commentator on chronic pain. Bagosy-Young , who the director of the event, is a patient advocate who has utilized social media to develop communities that address a myriad of issues facing chronic pain patients including, treatment modalities, and provider and insurance issues among other things. She also is a columnist for the National Pain Report. .
The Midwest Pain Summit will be held August 15th at the Hilton in Northbrook, Illinois (which is near Chicago).
“While Midwesterners are urged to attend,” Bagosy-Young said,” we expect to see people from around the country attend the event again this year.”
In addition, it will be streamed live over the internet. Last year, people from as far away as Australia participated via the web.
Chronic Pain affects more than 100 million Americans.
According to the National Institutes of Health, pain affects more Americans than diabetes, heart disease and cancer combined.
Pain is cited as the most common reason Americans access the health care system. It is a leading cause of disability and it is a major contributor to health care costs.
For more information on how to register for the August 15th event, click here.
http://nationalpainreport.com/chronic-pain-patient-summit-set-for-chicago-area-8826672.html
Subscribe to:
Posts (Atom)





